Skip to main content
. Author manuscript; available in PMC: 2013 Sep 2.
Published in final edited form as: Neuropeptides. 2012 Feb 10;46(2):81–91. doi: 10.1016/j.npep.2012.01.001

Figure 5.

Figure 5

Effects on mRNA levels of galanin (GAL), tyrosine hydroxylase (TH), galanin receptors type 1, 2, and 3 (GalR1, GalR2, GalR3), and β-Actin (Parts A-F) in the dorsal raphe region (DRN) of the brain following chronic administration (for two weeks) of one of three AD drugs -- phenelzine (PHE), desipramine (DMI), and paroxetine (PAR) -- or vehicle (VEH). The number of animals in each group after excluding six samples that were measured incorrectly were VEH n=7; PHE n=7; DMI n=7; and PAR n=6. All other details as described in legend for Figure 2, except for the statistical comparisons for which groups receiving different AD drugs were also compared with each other. Statistically significant differences are noted as follows: σ = significantly (p<0.05) higher than VEH. γ = significantly (p < 0.05) lower than PAR.